Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 32961 [2014-13389]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 110 / Monday, June 9, 2014 / Notices
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–13346 Filed 6–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Atlanta, Georgia 30333, telephone 404/639–
8836; Email ACIP@CDC.GOV.
Meeting is webcast live via the World Wide
Web; for instructions and more information
on ACIP please visit the ACIP Web site:
https://www.cdc.gov/vaccines/acip/
index.html.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
ehiers on DSK2VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
This notice is being published on less than
15 days prior to the meeting date because no
earlier notification of the meeting was
practicable.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–13389 Filed 6–6–14; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2014–13387 Filed 6–6–14; 8:45 am]
Times and Dates:
8:00 a.m.–6:00 p.m., June 25, 2014.
8:00 a.m.–1:30 p.m., June 26, 2014.
Place: Centers for Disease Control and
Prevention, Tom Harkin Global
Communications Center, 1600 Clifton Road
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate use of immunizing agents. In
addition, under 42 U.S.C. § 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at
section 2713 of the Public Health Service
Act, immunization recommendations of the
ACIP that have been adopted by the Director
of the Centers for Disease Control and
Prevention must be covered by applicable
health plans.
Matters for Discussion: The agenda will
include discussions on: Yellow fever vaccine,
human papillomavirus vaccines, influenza,
pneumococcal conjugate vaccine, tetanus,
diphtheria, and acellular pertussis vaccine in
healthcare personnel, meningococcal
vaccines, child/adolescent immunization,
adult immunization, immunization safety,
measles, hepatitis vaccines and vaccine
supply. Recommendation votes are
scheduled for yellow fever vaccine and
influenza. Time will be available for public
comment.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
32961
VerDate Mar<15>2010
15:08 Jun 06, 2014
Jkt 232001
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Demonstration Projects on
Health Systems Change to Integrate
Tobacco Dependence Treatment into
Clinical Care and Assessment of Related
Outcomes, Special Interest Projects
(SIP)14–028; and Applied Research and
Development of Tools to Address Pointof-Sale Tobacco Marketing, SIP14–029,
Panel B, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9:00 a.m.–6:00 p.m., June
18, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Demonstration Projects on
Health Systems Change to Integrate Tobacco
Dependence Treatment into Clinical Care and
Assessment of Related Outcomes, SIP14–028;
and Applied Research and Development of
Tools to Address Point-of-Sale Tobacco
Marketing, SIP14–029, Panel B, initial
review.’’
Contact Person for More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
The meeting announced below
concerns Global and Territorial Health
Research Network—Coordinating
Center, Special Interest Projects
(SIP)14–021; and Global and Territorial
Health Research Network—
Collaborating Centers, SIP14–022, Panel
C, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9:00 a.m.–6:00 p.m., June
17, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Global and Territorial Health
Research Network—Coordinating Center,
SIP14–021; and Global and Territorial Health
Research Network—Collaborating Centers,
SIP14–022, Panel C, initial review.’’
Contact Person for More Information:
Diana Bartlett, M.P.H., M.P.P., Health
Scientist, CDC, 1600 Clifton Road NE.,
Mailstop D–72, Atlanta, Georgia 30333,
Telephone: (404) 639–4938, ZXD5@
CDC.GOV.
This notice is being published on less than
15 days prior to the meeting date because no
earlier notification of the meeting was
practicable.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
E:\FR\FM\09JNN1.SGM
09JNN1
]]>Agencies
[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Page 32961]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Demonstration Projects on
Health Systems Change to Integrate Tobacco Dependence Treatment into
Clinical Care and Assessment of Related Outcomes, Special Interest
Projects (SIP)14-028; and Applied Research and Development of Tools to
Address Point-of-Sale Tobacco Marketing, SIP14-029, Panel B, initial
review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 9:00 a.m.-6:00 p.m., June 18, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Demonstration Projects on Health Systems Change to
Integrate Tobacco Dependence Treatment into Clinical Care and
Assessment of Related Outcomes, SIP14-028; and Applied Research and
Development of Tools to Address Point-of-Sale Tobacco Marketing,
SIP14-029, Panel B, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
This notice is being published on less than 15 days prior to the
meeting date because no earlier notification of the meeting was
practicable.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-13389 Filed 6-6-14; 8:45 am]
BILLING CODE 4163-18-P
